FUS and amyotrophic lateral sclerosis: Moreover, Yasuda and collaborators demonstrated for the first time that engineered HSP104 variants are able to dissolve cytoplasmic ALS-linked FUS aggregates in mammalian cells (Yasuda et al., 2017).